	Adalimumab Reduces Epicardial Adipose Tissue in Psoriasis: A Post Hoc Analysis of a Randomized Placebo-Controlled Clinical Trial. Psoriasis (Auckl) Ramessur R, Kernizan F, Ranjbar E, Mehta NN, Alavi A, Shin DB, Iacobellis G, Gelfand JM. PMID: 42694939 [PubMed]
	Fibromyalgia and Central Sensitization in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: A Systematic Review. Cureus Eltoum HA, Hashim NTO, Mohammed SA, Hassanelbasri DG, Ahmed A, Alamin MA. PMID: 42694713 [PubMed]
	Onychoscopy in Nail Psoriasis: A Narrative Review of Diagnostic Utility, Disease Severity Assessment, Musculoskeletal Associations, and Treatment Monitoring. Cureus Sethumadhavan K, Sekar M, Srivenkateswaran K. PMID: 42694524 [PubMed]
	Shared Treg dysregulation underlies psoriasis vulgaris and atopic dermatitis through the PHF19-PRC2 epigenetic axis. Front Immunol Lin Y, Su X, Jin M, Wang Y, Li Y, Zong B, Song H, Lv Y, Liu Z, Wang G, Wu S. PMID: 42694095 [PubMed - indexed for MEDLINE]
	Factors associated with drug adherence in psoriasis: aÂ single-center, retrospective, questionnaire-based exploratory study in Bavaria. J Dtsch Dermatol Ges Jalili-Tazeshahri N, Huppertz G, Kurz B, von Eichborn MI, Berneburg M, Maisch T, Niebel D. PMID: 42693887 [PubMed - as supplied by publisher]
	Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial. Br J Dermatol Yang B, Li Y, Wang Y, Yang L, Feng Y, Ding Y, Li S, Man X, Jiang C, Wu L, Shen Z, Wang X, Zhang Z, Li L, Tu Y, Lei T, Ji K, Ji C, Xiang N, Wang J, Zhan Y, Xu B, Chen Q, Ma X, Cui X, Jia H, Li B, Ma C, Zhou G, Qian Q, Situ X, Zhu X, Zhou C, Zhang J, Zhang F. PMID: 42687756 [PubMed - as supplied by publisher]
	Managing comorbidities in psoriatic arthritis: A state-of-the-art approach to integrated care (2025). Best Pract Res Clin Rheumatol Tancer S, Elaine Husni M. PMID: 42686511 [PubMed - as supplied by publisher]
	Investigating the molecular drivers of high-level clinical responses to bimekizumab in psoriatic disease: Introducing the BE UNIQUE phase 3b study. J Invest Dermatol Gudjonsson JE, Merola JF, Warren RB, McInnes IB, Szilagyi B, Simon-Hinsberg C, Jones P, Rastrick J, Cleverly A, Cutcutache I, Krueger JG. PMID: 42678333 [PubMed - as supplied by publisher]
	The association between psoriasis and body mass index: an observational retrospective study of 184 patients. Folia Med (Plovdiv) Kamber D, Gospodinova K, Gincheva V, Yordanova I, Gospodinov D. PMID: 42677783 [PubMed - indexed for MEDLINE]
	Ocular complications in psoriasis and psoriatic arthritis. Reumatologia Nitskovich R, Suchecka A, Ma, Kopacz D, Herniczek W, Walecka I. PMID: 42677195 [PubMed]
	The placebo effect in psoriatic arthritis. Autoimmun Rev Motta F, Cannistrà C, Tonutti A, Selmi C. PMID: 42674135 [PubMed - as supplied by publisher]
	Findings Interpretation Concerns Regarding the Emulated Target Trial of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Psoriatic Arthritis [Letter]. Drug Des Devel Ther Lymperopoulos A, Leiker MG. PMID: 42668988 [PubMed - in process]
	Clinical practice guideline for psoriasis management in Latin America. An Bras Dermatol Valenzuela F, Castro Ayarza JR, Kaplan D, Londoño-García AM, Macías García KDR, Magariños G, Rivas Záldivar ES, Franco M, Cano S, Cortés C, Cárdenas PJ, Castro C, Ferreira R, Martínez S, Ibatá Bernal L, Castillo JC, Ospina J. PMID: 42667799 [PubMed - as supplied by publisher]
	DNA hypo-methylation of the TNFÎ‘ gene predicts response to methotrexate in rheumatoid arthritis but not in psoriatic arthritis. Rheumatology (Oxford) Dalix E, Pitaksalee R, De Marco G, Parmar R, Thomas S, Ng H, Shuweihdi F, Kingsbury SR, Marzo-Ortega H, Conaghan PG, Emery P, Marotte H, Ponchel F. PMID: 42664067 [PubMed - as supplied by publisher]
	Safety of Icotrokinra Through 1Â Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCEÂ 1 and 2 PhaseÂ 3 Trials. Dermatol Ther (Heidelb) Lebwohl MG, Gooderham M, Warren RB, Eichenfield LF, Rubens JH, Cardillo T, Russo C, DeKlotz CMC, Miller-Kassamali M, Anaya Velarde L, Hsu MC, Li S, Yang YW, Ofori S, Bissonnette R, Soung J, Hebert AA, Stein Gold L. PMID: 42663861 [PubMed - as supplied by publisher]
	IL-4RÎ± antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies. Front Immunol Zhang Y, He Y, Leng R, Liu W, Zhou X, Yang J. PMID: 42661770 [PubMed - indexed for MEDLINE]
	IL-17 ligand-targeting inhibitors in psoriatic arthritis: a focused systematic review and network meta-analysis of efficacy, safety, and certainty of evidence. Front Immunol AbuJwaid YK, Assi AK, Amro AM, Awwad HH, Ehmidat M, Deeb S, Awlad Mohammad MW, Dwayat A, Odeh A, Albow Y, Yasini M, Alfrookh M, Alamlih L. PMID: 42661716 [PubMed - indexed for MEDLINE]
	Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF: post hoc analysis of SELECT-PsA 2. RMD Open Coates LC, Mease P, Kavanaugh A, Merola JF, Magrey M, Iyile T, Zhou L, Novelli L, Lagunes I, Setty AR, Van den Bosch F. PMID: 42660564 [PubMed - indexed for MEDLINE]
	Longitudinal Interferon-Î³ Release Assay Changes in Psoriasis Treated With Interleukin Inhibitors: A Single-Center Real-World Cohort Study in China. J Am Acad Dermatol Liao S, Liu C, Chen X, Liu X, Xiong J, Wang P, Hu R, Deng X, Pan Y, Yu RT, Huang K. PMID: 42660434 [PubMed - as supplied by publisher]
	A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis. Acta Derm Venereol Maul JT, Fargnoli MC, Gkalpakiotis S, Lambert J, Pinter A, Ruiz-Villaverde R, Sator P, Tzellos T. PMID: 42658202 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 28473

Page 1 of 1424



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy